Example: Heart Attack

Search clinical trials for: Carboplatin

Total 2604 results

NCT04465942

Recruiting

Immunotherapy in Lung Cancer: Treatment After IO Cessation.

Conditions: Carcinoma, Non-Small-Cell Lung; Immunotherapy
NCT04466917

Not yet recruiting

A Study of ABP 215 Versus Bevacizumab in Chinese Subjects With Advanced Non-Squamous Non-Small Cell Lung Cancer

Conditions: Metastatic Non-small Cell Lung Cancer (NSCLC); Non-squamous NSCLC
NCT04464174

Not yet recruiting

Ipatasertib Plus Non-Taxane Chemotherapy for Advanced or Metastatic Triple-Negative Breast Cancer

Conditions: Triple Negative Breast Cancer
NCT04460807

Recruiting

Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer

Conditions: Ovarian Cancer
NCT04457089

Not yet recruiting

Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer

Conditions: Recurrent Ovarian Cancer; Platinum-sensitive Ovarian Cancer
NCT04458909

Not yet recruiting

Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer

Conditions: Metastatic Nasopharyngeal Carcinoma; Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma; Metastatic Nasopharyngeal Undifferentiated Carcinoma; Nasopharyngeal Nonkeratinizing Carcinoma; Recurrent Nasopharyngeal Carcinoma; Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma; Recurrent Nasopharyngeal Undifferentiated Carcinoma; Stage IV Nasopharyngeal Carcinoma AJCC v8; Stage IVA Nasopharyngeal Carcinoma AJCC v8; Stage IVB Nasopharyngeal Carcinoma AJCC v8
NCT04459611

Not yet recruiting

Neoadjuvant of Sintilimab Combined With Chemotherapy for Resectable NSCLC（neoSCORE）

Conditions: Non-small Cell Lung Cancer
NCT04460352

Not yet recruiting

A Study of Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Cancer of the Esophagus

Conditions: Esophageal Squamous Cell Carcinoma
NCT04455594

Not yet recruiting

Almonertinib Vs. Erlotinib/Chemotherapy for Neo-adjuVant Treatment of Stage IIIA-N2 EGFR-mutated NSCLC

Conditions: Non-Small Cell Lung Cancer Stage IIIA
NCT04453423

Not yet recruiting

Combination Chemotherapy With or Without Anlotinib in the Maintenance Treatment of Non-Squamous Non-Small Cell Lung Cancer.

Conditions: Non-squamous Non-small-cell Lung Cancer
NCT04453904

Recruiting

Modality of Adjuvant Radiotherapy and Chemotherapy for Stage Ⅲ Endometrial Cancer

Conditions: Endometrial Cancer
NCT04453930

Recruiting

A Study of Sequential Therapy of Camrelizumab Combined With Chemotherapy（Irinotecan Plus Platinum）and With Apatinib in Participants With Untreated Advanced Small Cell Lung Cancer（SCLC）

Conditions: Small Cell Lung Carcinoma
NCT04449861

Not yet recruiting

Durvalumab Plus Chemotherapy in ES-SCLC (Oriental)

Conditions: Small Cell Lung Carcinoma Extensive Disease
NCT04444921

Not yet recruiting

Testing the Addition of Nivolumab to Chemotherapy for Patients With Metastatic Anal Cancer

Conditions: Anal Basaloid Carcinoma; Anal Canal Cloacogenic Carcinoma; Metastatic Anal Squamous Cell Carcinoma; Recurrent Anal Squamous Cell Carcinoma; Stage III Anal Cancer AJCC v8; Stage IIIA Anal Cancer AJCC v8; Stage IIIB Anal Cancer AJCC v8; Stage IIIC Anal Cancer AJCC v8; Stage IV Anal Cancer AJCC v8; Unresectable Anal Squamous Cell Carcinoma
NCT04443348

Not yet recruiting

Pre-op Pembro + Radiation Therapy in Breast Cancer

Conditions: Triple Negative Breast Cancer; Hormone Receptor Positive (HR+), HER2-negative Breast Cancer; Biopsy-proven, Positive Lymph Node(s)
NCT04439890

Recruiting

A Efficacy and Safety Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy Versus Placebo Combined With Chemotherapy as First-line Treatment in Subjects With Advanced Non-squamous Cell Non-small Cell Lung Cancer

Conditions: Advanced Non-squamous Cell Non-small Cell Lung Cancer
NCT04440358

Not yet recruiting

Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM

Conditions: Recurrent Glioblastoma
NCT04435197

Not yet recruiting

Pre-Operative Pembrolizumab + Chemoradiation in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma

Conditions: Esophageal Squamous Cell Carcinoma
NCT04430933

Not yet recruiting

A Safety and Tolerability Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metastatic NSCLC

Conditions: Advanced or Metastatic Solid Tumors; Non-Small Cell Lung Cancer
NCT04425070

Not yet recruiting

A Study of Evaluating the Safety and Efficacy of ATG-010 Combined With Chemotherapy Sequential With ATG-010 Monotherapy Maintenance in Peripheral T- and NK/T-cell Lymphoma

Conditions: Peripheral T-cell Lymphoma; NK/T-cell Lymphoma
NCT04425135

Not yet recruiting

Camrelizumab Combined With Apatinib Mesylate and Standard Chemotherapy (Pemetrixed + Carboplatin) in Patients With Tyrosine Kinase Inhibitor Failure in ALK-positive Advanced NSCLC

Conditions: Lung Neoplasms
NCT04428333

Not yet recruiting

Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Conditions: Neoplasms, Head and Neck
NCT04422210

Recruiting

A Study Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Venetoclax In Combination With Atezolizumab, Carboplatin, And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC).

Conditions: Small Cell Lung Cancer
NCT04422392

Not yet recruiting

Neoadjuvant PD-1 Antibody Plus Chemotherapy in Resectable Stage IIIA-N2 Non-Small-Cell Lung Cancer

Conditions: Non Small Cell Lung Cancer
NCT04419181

Not yet recruiting

Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast Cancer

Conditions: HER2-positive Breast Cancer
NCT04415944

Recruiting

Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy

Conditions: Ovarian Epithelial Cancer Stage I; Ovarian Epithelial Cancer Stage II; Ovarian Epithelial Cancer Stage III; Stage I Fallopian Tube Cancer; Stage II Fallopian Tube Cancer; Stage III Fallopian Tube Cancer; Peritoneal Carcinoma
NCT04416035

Not yet recruiting

A Study to Compare the Similarity in Efficacy and Safety Between TRS003 and China-approved Bevacizumab® in NSCLC

Conditions: Advanced Non-squamous Non-small-cell Lung Cancer
NCT04417088

Not yet recruiting

Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy

Conditions: Recurrent Glioblastoma
NCT04410796

Recruiting

Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

Conditions: Metastatic Non-small Cell Lung Cancer
NCT04405674

Not yet recruiting

Tislelizumab Combined With Chemotherapy in Patients With TKI-Resistant EGFR-Mutated Non-squamous NSCLC

Conditions: Non Small Cell Lung Cancer
NCT04399876

Not yet recruiting

Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer

Conditions: Prostate Cancer; Radical Prostatectomy
NCT04397003

Not yet recruiting

Personalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) and Tremelimumab in Extensive Stage Small Cell Lung Cancer

Conditions: Extensive-stage Small Cell Lung Cancer
NCT04391049

Not yet recruiting

Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery

Conditions: Advanced Esophageal Adenocarcinoma; Advanced Gastroesophageal Junction Adenocarcinoma; Clinical Stage II Esophageal Adenocarcinoma AJCC v8; Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8; Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8; Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage III Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage II Esophageal Adenocarcinoma AJCC v8; Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8; Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8; Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage III Esophageal Adenocarcinoma AJCC v8; Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8; Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8; Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8; Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8; Unresectable Gastroesophageal Junction Adenocarcinoma
NCT04387227

Not yet recruiting

Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Conditions: Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma
NCT04380636

Recruiting

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

Conditions: Lung Neoplasms; Carcinoma, Non-Small-Cell Lung
NCT04379635

Recruiting

Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC)

Conditions: Non Small Cell Lung Cancer
NCT04379739

Not yet recruiting

Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer

Conditions: Non Small Cell Lung Cancer
NCT04367909

Recruiting

A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell Carcinoma

Conditions: Oral Squamous Cell Carcinoma
NCT04363255

Not yet recruiting

First-line Chemotherapy Followed by Toripalimab Combined With Anlotinib for Maintenance in ES-SCLC

Conditions: Small Cell Lung Carcinoma
NCT04364048

Recruiting

Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer

Conditions: Lung Cancer; Non-small Cell Carcinoma
NCT04354961

Not yet recruiting

Almonertinib Versus Paclitaxel Plus Carboplatin as First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic Pulmonary Adenosquamous Carcinoma （ARISE）

Conditions: Pulmonary Adenosquamous Carcinoma
NCT04351555

Not yet recruiting

A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer

Conditions: Non-Small Cell Lung Cancer
NCT04346914

Recruiting

Study of ZKAB001 Combined With Carboplatin and Etoposide in the Extensive Small Cell Lung Cancer

Conditions: Extensive Stage Small Cell Lung Cancer
NCT04339218

Not yet recruiting

Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma

Conditions: Lung Adenocarcinoma; Cryotherapy Effect
NCT04337632

Recruiting

Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum—Partial Sensitive Recurrent Ovarian Cancer

Conditions: Ovarian Cancer
NCT04335292

Not yet recruiting

Osimertinib Then Chemotherapy in EGFR-mutated Lung Cancer With Osimertinib Third-line Rechallenge

Conditions: Non-Small Cell Lung Cancer
NCT04335669

Recruiting

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

Conditions: Breast Cancer; Triple Negative Breast Neoplasms
NCT04331067

Not yet recruiting

Cabiralizumab in Combination With Nivolumab and Neoadjuvant Chemotherapy in Patients With Localized Triple-negative Breast Cancer

Conditions: Triple Negative Breast Cancer
NCT04332367

Recruiting

Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance

Conditions: Non-small Cell Lung Cancer
NCT04326153

Recruiting

Neoadjuvant Immunotherapy Plus Chemotherapy for Resectable Stage IIIA Non-Small Cell Lung Cancer

Conditions: IIIA Stage Non-small Cell Lung Cancer

Search clinical trials for: Carboplatin

Recent CRA jobs

Business Analyst (Salesforce)

Site Management Coordinator (Cape Town, Centurion or Bloemfontein based)

Dev Opns Engineer

Business Analyst - SaaS CRMs (Salesforce)

Centralized Monitoring Lead (Homebased)

Freelance- Translators/Linguists, Polish language

Jovem Aprendiz

Senior/Safety Specialist (Home/Office-Based) - IQVIA Biotech

Patient Pathway and Support Program Internship

Lead Contracts Analyst